The FMC1 gene helps mitochondria, the energy-making parts of cells, build a key machine called ATP synthase, which cells use to make usable energy. When both copies carry pathogenic variants, the body may struggle to meet energy needs, especially in the brain, muscles, heart, and liver. This can lead to a mitochondrial condition with symptoms such as low muscle tone, feeding problems, developmental delay, breathing problems, or high lactic acid levels.
What is a gene?
A gene is a section of DNA that carries instructions your cells use to make molecules or direct activities in the body. Some genes provide the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
FMC1Gene function
What if the gene works
The FMC1 gene helps mitochondria assemble ATP synthase, which supports energy production in cells. This is especially important in organs like the heart and brain that need steady fuel.
Risk
What if the gene does not work
Biallelic variants in the FMC1 gene can cause a mitochondrial condition, often starting in infancy, with low muscle tone, feeding or breathing problems, developmental delay, and sometimes heart involvement. Milder or more severe variants can affect onset and severity.
Treatment
What does that mean for your treatment
No FMC1-specific treatment or drug choice is currently established for people with a pathogenic or loss-of-function variant in the FMC1 gene.
Gene function
What if the gene works
In your cells, the FMC1 gene supports the mitochondria, the parts of cells that make most of your usable energy. It helps one of their main energy-making machines form and stay stable. Understanding the FMC1 gene function helps explain how cells keep a steady supply of ATP, the energy cells use every day.
Inside mitochondria, the FMC1 gene helps build ATP synthase, an energy-making machine also called complex V. It supports the proper formation and stability of this machine so ATP production can run smoothly.
By helping ATP synthase work as it should, the FMC1 gene supports a reliable flow of ATP for everyday cell tasks. This helps cells power routine activities such as movement, signaling, and repair.
What is a variant?
A genetic variant is a minor difference in a gene’s DNA sequence. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body reacts to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Some FMC1 gene variants affect mitochondrial ATP synthase assembly by making the protein unstable or unable to support final complex formation. This can leave fewer working energy-making units in mitochondria, so cells produce less usable energy. Milder variants may leave partial activity, while more severe loss of function variants can leave little or no residual function and are more often linked to earlier and more marked mitochondrial disease.
How variants are linked to conditions
Among FMC1 gene variants linked to conditions, the clearest finding is a rare inherited mitochondrial condition called combined oxidative phosphorylation deficiency 16 (a condition that can affect the brain, muscles, and development). People with pathogenic variants in the FMC1 gene often develop symptoms in infancy or early childhood. Reported features include low muscle tone, feeding problems, developmental delay, movement difficulties, seizures, and high lactate levels on lab tests.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not directly affect health and simply contribute to natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For FMC1, risk is mainly set by genetics rather than lifestyle. A child’s chance of having the related condition is higher when both parents carry a harmful FMC1 change, so family history and parents being blood relatives can raise the chance in some families.
Inheritance of FMC1 variants
FMC1-related conditions are inherited in an autosomal recessive pattern. In practical terms, how FMC1 gene variants are inherited usually means a child receives one altered copy of the FMC1 gene from each parent. Parents who carry one variant often do not have symptoms themselves. When both parents are carriers, each pregnancy has a 25% chance of resulting in a child with the condition, a 50% chance that the child will be a carrier, and a 25% chance that the child will inherit neither variant.
What does my FMC1 result mean for my family?
For FMC1-related illness, the family pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also have the condition or be carriers, so close relatives may want to learn whether the same gene change runs in the family. Children of someone with an FMC1-related condition will usually be carriers unless the other parent also carries an FMC1 change.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for FMC1 variants uses a blood or saliva sample to read the FMC1 gene. It is often included in a panel that checks many genes at once or in broader DNA sequencing. Results may show a relevant variant, no variant, or a variant of uncertain significance, which means the finding is not yet fully understood.
When should I consider getting a genetic test?
Genetic testing for the FMC1 gene may be considered when a baby or child has signs of a rare inherited mitochondrial condition, such as severe muscle weakness, feeding trouble, delayed development, or heart problems, especially if similar illness runs in the family. It can also help clarify the chance of the condition happening again in future pregnancies.
A genetic result is only one part of your health story
Genetic findings can give useful insight, but how much they explain varies with the condition and the kind of variant present. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and is most helpful when considered with other parts of care. In other situations, a genetic result can give a clear answer. For medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target, so the same treatment may work better for one person and cause more side effects in another. These differences are common and help explain why medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in genes can shape the way a person responds to medication. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes can affect how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more personalized. You can read more about this topic in the LearnHub.
Drugs influenced by the FMC1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
In the late 1990s and early 2000s, researchers studying yeast identified FMC1 as a gene involved in cell energy production under heat stress. Building on this early work, scientists then looked for a human counterpart and began to define the FMC1 gene in people. Over time, descriptions became more precise as genetic studies linked rare variants in the FMC1 gene to mitochondrial disease, including Leigh syndrome. This was an important step because it connected earlier laboratory findings with an inherited condition seen in children. Although the FMC1 gene has not entered public discussion in the way some genes have, its history reflects how careful basic science can lead to clearer genetic diagnosis.